Kingmed Diagnostics: Expected net profit loss of RMB 65 million to RMB 95 million in the first half of 2025

Kingmed Diagnostics announced that it expects to achieve a net profit attributable to shareholders of the listed company of -65 million to -95 million yuan for the first half of 2025, a year-on-year turnaround from profit to loss. It is expected that the net profit attributable to shareholders of the listed company, after deducting non-recurring gains and losses, will be -78 million to -110 million yuan for the first half of 2025